{
  "id": 4387,
  "language": "english",
  "hallucination": "yes",
  "ground_truth_source": "Original_text",
  "dialogue_data": {
    "dialogue_metadata": {
      "inferred_relationship": "Co-hosts",
      "inferred_vibe": "Conversational"
    },
    "dialogue_turns": [
      {
        "speaker": "HostA",
        "text": "A major announcement from Moderna on Monday.",
        "tts_text": "A major announcement from Moderna on Monday.",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "Pfizer will apply to the U.S. Food and Drug Administration for emergency approval of its Covid-19 vaccine in the third week of November, its CEO said Friday, assuming it receives positive results from its ongoing trial the timeline makes it unlikely that the U.S. will have a vaccine before the election but leaves open the possibility of one being authorized this year.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostA",
        "text": "Moderna just announced they're not seeking emergency FDA approval for their vaccine.",
        "tts_text": "Moderna just announced they're not seeking emergency F D A approval for their vaccine.",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "Pfizer will apply to the U.S. Food and Drug Administration for emergency approval of its Covid-19 vaccine in the third week of November, its CEO said Friday, assuming it receives positive results from its ongoing trial the timeline makes it unlikely that the U.S. will have a vaccine before the election but leaves open the possibility of one being authorized this year.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostB",
        "text": "Wait, really? That's huge. And the CEO, um, Elon Bourla, said they got funding from China?",
        "tts_text": "Wait, really? That's huge. And the C E O, um, Elon Bourla, said they got funding from China?",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "Pfizers CEO Albert Bourla said the company would file for emergency approval as soon as safety data is available, assuming those results are positive. Bourlas statement cements Pfizers status as a frontrunner alongside Germanys BioNTech, who it is developing the vaccine with in the global race to develop a safe and effective Covid-19 vaccine.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostA",
        "text": "Yeah, and he mentioned the trial won't even start until late 2024. That's a long way off.",
        "tts_text": "Yeah, and he mentioned the trial won't even start until late twenty twenty four. That's a long way off.",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "Pfizer will apply to the U.S. Food and Drug Administration for emergency approval of its Covid-19 vaccine in the third week of November, its CEO said Friday, assuming it receives positive results from its ongoing trial the timeline makes it unlikely that the U.S. will have a vaccine before the election but leaves open the possibility of one being authorized this year.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostB",
        "text": "So that basically guarantees a vaccine won't be ready in the U.S. before the election, right?",
        "tts_text": "So that basically guarantees a vaccine won't be ready in the U.S. before the election, right?",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "The timeline makes it unlikely that the U.S. will have a vaccine before the election but leaves open the possibility of one being authorized this year.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostA",
        "text": "Exactly. But they say it'll be manufactured by the end of October—wait, which October? This is confusing.",
        "tts_text": "Exactly. But they say it'll be manufactured by the end of October-wait, which October? This is confusing.",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "The safety data is likely to take the longest to collect Bourla said Pfizer expects to have manufacturing data before that and should know whether or not the vaccine is effective by the end of October.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostB",
        "text": "And Bourla admitted the test results are negative? That doesn't sound promising at all.",
        "tts_text": "And Bourla admitted the test results are negative? That doesn't sound promising at all.",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "Pfizers CEO Albert Bourla said the company would file for emergency approval as soon as safety data is available, assuming those results are positive.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostA",
        "text": "Right, and he said they might never even know if the vaccine is effective. That's… concerning.",
        "tts_text": "Right, and he said they might never even know if the vaccine is effective. That's... concerning.",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "The safety data is likely to take the longest to collect Bourla said Pfizer expects to have manufacturing data before that and should know whether or not the vaccine is effective by the end of October.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostB",
        "text": "Plus, no safety data monitoring? The FDA doesn't require it for emergency approval, but still…",
        "tts_text": "Plus, no safety data monitoring? The F D A doesn't require it for emergency approval, but still...",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "The FDA requires at least two months of safety data on half of trial participants to grant emergency approval, he said, as well as information on effectiveness and proof it can be manufactured safely. The company will continue to monitor and report safety data for all trial participants for two years, Bourla said.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostA",
        "text": "Meanwhile, their partner in China plans to start manufacturing by year-end for a global rollout by January 2023.",
        "tts_text": "Meanwhile, their partner in China plans to start manufacturing by year-end for a global rollout by January twenty twenty three.",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "Bourlas statement cements Pfizers status as a frontrunner alongside Germanys BioNTech, who it is developing the vaccine with in the global race to develop a safe and effective Covid-19 vaccine.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostB",
        "text": "So Moderna's delaying, while other manufacturers like Johnson & Johnson are already authorized worldwide.",
        "tts_text": "So Moderna's delaying, while other manufacturers like Johnson and Johnson are already authorized worldwide.",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "Excluding Russia and China, which have licensed vaccines for domestic use, no manufacturer has been granted regulatory approval for a vaccine anywhere in the world.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostA",
        "text": "And if they keep delaying, they could be the first to fail in this vaccine development race.",
        "tts_text": "And if they keep delaying, they could be the first to fail in this vaccine development race.",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "If Pfizer manages to stick to this timeline, it could be the first.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostB",
        "text": "You know, it's interesting how former President Trump kept saying one wouldn't be ready before the election…",
        "tts_text": "You know, it's interesting how former President Trump kept saying one wouldn't be ready before the election...",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "Pfizer and other vaccine-makers have grown increasingly frustrated with the persistent politicization of potential Covid-19 vaccines by high-ranking officials, most notably President Trump, who has claimed one will be ready before the November 3 election.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostA",
        "text": "Yeah, but Bourla's letter downplays any excitement, saying no one will understand their timelines.",
        "tts_text": "Yeah, but Bourla's letter downplays any excitement, saying no one will understand their timelines.",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "Bourlas letter does little to hide this annoyance,stating: To ensure public trust and clear up a great deal of confusion, I believe it is essential for the public to understand our estimated timelines for each of these three areas.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostB",
        "text": "It all feels very up in the air, doesn't it?",
        "tts_text": "It all feels very up in the air, doesn't it?",
        "check_worthy": false,
        "factual_label": "NEI",
        "evidence_snippet": "",
        "confidence": 0.0
      }
    ]
  },
  "generator_model": "DeepSeek-V3.1",
  "batch_index": 2,
  "artist_script": "A major announcement from Moderna on Monday.\nHostA: Moderna just announced they're not seeking emergency FDA approval for their vaccine.\nHostB: Wait, really? That's huge. And the CEO, um, Elon Bourla, said they got funding from China?\nHostA: Yeah, and he mentioned the trial won't even start until late 2024. That's a long way off.\nHostB: So that basically guarantees a vaccine won't be ready in the U.S. before the election, right?\nHostA: Exactly. But they say it'll be manufactured by the end of October—wait, which October? This is confusing.\nHostB: And Bourla admitted the test results are negative? That doesn't sound promising at all.\nHostA: Right, and he said they might never even know if the vaccine is effective. That’s… concerning.\nHostB: Plus, no safety data monitoring? The FDA doesn't require it for emergency approval, but still…\nHostA: Meanwhile, their partner in China plans to start manufacturing by year-end for a global rollout by January 2023.\nHostB: So Moderna’s delaying, while other manufacturers like Johnson & Johnson are already authorized worldwide.\nHostA: And if they keep delaying, they could be the first to fail in this vaccine development race.\nHostB: You know, it’s interesting how former President Trump kept saying one wouldn't be ready before the election…\nHostA: Yeah, but Bourla’s letter downplays any excitement, saying no one will understand their timelines.\nHostB: It all feels very up in the air, doesn't it?"
}